Suchergebnisse - "Prostatic Neoplasms (mesh)"

Pathologist-like explainable AI for interpretable Gleason grading in prostate cancer

Autoren: Mittmann, Gesa Laiouar-Pedari, Sara Mehrtens, Hendrik A et al.

Quelle: Nature Communications. 16(1)

Schlagwörter: 46 Information and Computing Sciences (for-2020), 32 Biomedical and Clinical Sciences (for-2020), 3211 Oncology and Carcinogenesis (for-2020), Urologic Diseases (rcdc), Machine Learning and Artificial Intelligence (rcdc), Prostate Cancer (rcdc), Aging (rcdc), Networking and Information Technology R&D (NITRD) (rcdc), Cancer (rcdc), Humans (mesh), Male (mesh), Prostatic Neoplasms (mesh), Neoplasm Grading (mesh), Artificial Intelligence (mesh), Pathologists (mesh), Observer Variation (mesh), Prostate (mesh), Prostate (mesh), Humans (mesh), Prostatic Neoplasms (mesh), Observer Variation (mesh), Artificial Intelligence (mesh), Male (mesh), Neoplasm Grading (mesh), Pathologists (mesh), Humans (mesh), Male (mesh), Prostatic Neoplasms (mesh), Neoplasm Grading (mesh), Artificial Intelligence (mesh), Pathologists (mesh), Observer Variation (mesh), Prostate (mesh)

Dateibeschreibung: application/pdf

Zugangs-URL: https://escholarship.org/uc/item/8543h984
https://escholarship.org/content/qt8543h984/qt8543h984.pdf

Patterns of telehealth use in newly diagnosed prostate cancer patients

Autoren: Eyrich, Nicholas W Patil, Dattatraya Marthi, Siddharth et al.

Quelle: Urologic Oncology Seminars and Original Investigations. 43(9)

Schlagwörter: 32 Biomedical and Clinical Sciences (for-2020), 3202 Clinical Sciences (for-2020), 3211 Oncology and Carcinogenesis (for-2020), Aging (rcdc), Prostate Cancer (rcdc), Health Disparities (rcdc), Cancer (rcdc), Urologic Diseases (rcdc), Networking and Information Technology R&D (NITRD) (rcdc), Cancer (hrcs-hc), 3 Good Health and Well Being (sdg), Humans (mesh), Male (mesh), Prostatic Neoplasms (mesh), Telemedicine (mesh), Aged (mesh), United States (mesh), Middle Aged (mesh), COVID-19 (mesh), Humans (mesh), Prostatic Neoplasms (mesh), Telemedicine (mesh), Aged (mesh), Middle Aged (mesh), United States (mesh), Male (mesh), COVID-19 (mesh), Health services research, Prostate cancer, Telehealth, Telemedicine, Humans (mesh), Male (mesh), Prostatic Neoplasms (mesh), Telemedicine (mesh), Aged (mesh), United States (mesh), Middle Aged (mesh), COVID-19 (mesh), 1112 Oncology and Carcinogenesis (for), Urology & Nephrology (science-metrix), 3202 Clinical sciences (for-2020), 3211 Oncology and carcinogenesis (for-2020)

Zugangs-URL: https://escholarship.org/uc/item/76p229c7

Effective Treatment of Disseminated Prostate Cancer Using CD46-Targeted 225Ac Therapy

Autoren: Bidkar, Anil P Peter, Robin Wadhwa, Anju et al.

Quelle: Clinical Cancer Research. 31(14)

Schlagwörter: 32 Biomedical and Clinical Sciences (for-2020), 3202 Clinical Sciences (for-2020), 3211 Oncology and Carcinogenesis (for-2020), Radiation Oncology (rcdc), Urologic Diseases (rcdc), Biomedical Imaging (rcdc), Cancer (rcdc), Bioengineering (rcdc), Prostate Cancer (rcdc), 5.1 Pharmaceuticals (hrcs-rac), 5.5 Radiotherapy and other non-invasive therapies (hrcs-rac), Cancer (hrcs-hc), Male (mesh), Humans (mesh), Actinium (mesh), Animals (mesh), Mice (mesh), Zirconium (mesh), Cell Line, Tumor (mesh), Radiopharmaceuticals (mesh), Prostatic Neoplasms (mesh), Positron-Emission Tomography (mesh), Xenograft Model Antitumor Assays (mesh), Tissue Distribution (mesh), Radioimmunotherapy (mesh), Glutamate Carboxypeptidase II (mesh), Alpha Particles (mesh), Deferoxamine (mesh), Antigens, Surface (mesh), Radioisotopes (mesh), Cell Line, Tumor (mesh), Animals (mesh), Humans (mesh), Mice (mesh), Prostatic Neoplasms (mesh), Actinium (mesh), Zirconium (mesh), Radioisotopes (mesh), Deferoxamine (mesh), Glutamate Carboxypeptidase II (mesh), Antigens, Surface (mesh), Radiopharmaceuticals (mesh), Positron-Emission Tomography (mesh), Radioimmunotherapy (mesh), Xenograft Model Antitumor Assays (mesh), Tissue Distribution (mesh), Alpha Particles (mesh), Male (mesh), Male (mesh), Humans (mesh), Actinium (mesh), Animals (mesh), Mice (mesh), Zirconium (mesh), Cell Line, Tumor (mesh), Radiopharmaceuticals (mesh), Prostatic Neoplasms (mesh), Positron-Emission Tomography (mesh), Xenograft Model Antitumor Assays (mesh), Tissue Distribution (mesh), Radioimmunotherapy (mesh), Glutamate Carboxypeptidase II (mesh), Alpha Particles (mesh), Deferoxamine (mesh), Antigens, Surface (mesh), Radioisotopes (mesh), 1112 Oncology and Carcinogenesis (for), Oncology & Carcinogenesis (science-metrix), 3202 Clinical sciences (for-2020), 3211 Oncology and carcinogenesis (for-2020)

Zugangs-URL: https://escholarship.org/uc/item/7r1639xd

Colibactin Exerts Androgen-dependent and -independent Effects on Prostate Cancer

Autoren: Agrawal, Raag Al-Hiyari, Sarah Hugh-White, Rupert et al.

Quelle: European Urology Oncology. 8(3)

Schlagwörter: 32 Biomedical and Clinical Sciences (for-2020), 3202 Clinical Sciences (for-2020), 3211 Oncology and Carcinogenesis (for-2020), Urologic Diseases (rcdc), Aging (rcdc), Human Genome (rcdc), Cancer Genomics (rcdc), Digestive Diseases (rcdc), Genetics (rcdc), Prostate Cancer (rcdc), Cancer (rcdc), 2.2 Factors relating to the physical environment (hrcs-rac), 2.1 Biological and endogenous factors (hrcs-rac), Cancer (hrcs-hc), Humans (mesh), Male (mesh), Prostatic Neoplasms (mesh), Polyketides (mesh), Peptides (mesh), Dihydrotestosterone (mesh), Escherichia coli (mesh), Androgens (mesh), Aged (mesh), Middle Aged (mesh), Anaerobic bacteria, Cancer progression, Metagenomic sequencing, Metastases, Microbiota, Microbiome, Prognosis, Prostate cancer, Urine, 16S ribosomal amplicon sequencing, Humans (mesh), Escherichia coli (mesh), Prostatic Neoplasms (mesh), Dihydrotestosterone (mesh), Peptides (mesh), Androgens (mesh), Aged (mesh), Middle Aged (mesh), Male (mesh), Polyketides (mesh), Humans (mesh), Male (mesh), Prostatic Neoplasms (mesh), Polyketides (mesh), Peptides (mesh), Dihydrotestosterone (mesh), Escherichia coli (mesh), Androgens (mesh), Aged (mesh), Middle Aged (mesh), 3202 Clinical sciences (for-2020), 3211 Oncology and carcinogenesis (for-2020)

Dateibeschreibung: application/pdf

Zugangs-URL: https://escholarship.org/uc/item/3nd642wf
https://escholarship.org/content/qt3nd642wf/qt3nd642wf.pdf

Androgen Receptor Inhibition Increases MHC Class I Expression and Improves Immune Response in Prostate Cancer

Autoren: Chesner, Lisa N Polesso, Fanny Graff, Julie N et al.

Quelle: Cancer Discovery. 15(3)

Schlagwörter: 32 Biomedical and Clinical Sciences (for-2020), 3211 Oncology and Carcinogenesis (for-2020), 3204 Immunology (for-2020), Aging (rcdc), Prostate Cancer (rcdc), Immunotherapy (rcdc), Urologic Diseases (rcdc), Cancer (rcdc), 5.1 Pharmaceuticals (hrcs-rac), 6.1 Pharmaceuticals (hrcs-rac), 2.1 Biological and endogenous factors (hrcs-rac), Cancer (hrcs-hc), Male (mesh), Humans (mesh), Prostatic Neoplasms (mesh), Androgen Receptor Antagonists (mesh), Animals (mesh), Mice (mesh), Receptors, Androgen (mesh), Histocompatibility Antigens Class I (mesh), Cell Line, Tumor (mesh), Cell Line, Tumor (mesh), Animals (mesh), Humans (mesh), Mice (mesh), Prostatic Neoplasms (mesh), Receptors, Androgen (mesh), Histocompatibility Antigens Class I (mesh), Male (mesh), Androgen Receptor Antagonists (mesh), Male (mesh), Humans (mesh), Prostatic Neoplasms (mesh), Androgen Receptor Antagonists (mesh), Animals (mesh), Mice (mesh), Receptors, Androgen (mesh), Histocompatibility Antigens Class I (mesh), Cell Line, Tumor (mesh), 1112 Oncology and Carcinogenesis (for), 3101 Biochemistry and cell biology (for-2020), 3211 Oncology and carcinogenesis (for-2020)

Dateibeschreibung: application/pdf

Zugangs-URL: https://escholarship.org/uc/item/73k2x1gw
https://escholarship.org/content/qt73k2x1gw/qt73k2x1gw.pdf

PSMA-PET/CT Findings in Patients With High-Risk Biochemically Recurrent Prostate Cancer With No Metastatic Disease by Conventional Imaging

Autoren: Holzgreve, Adrien Armstrong, Wesley R Clark, Kevyn J et al.

Quelle: JAMA Network Open. 8(1)

Schlagwörter: 32 Biomedical and Clinical Sciences (for-2020), 3202 Clinical Sciences (for-2020), 3211 Oncology and Carcinogenesis (for-2020), Aging (rcdc), Health Disparities (rcdc), Biomedical Imaging (rcdc), Prostate Cancer (rcdc), Clinical Research (rcdc), Clinical Trials and Supportive Activities (rcdc), Urologic Diseases (rcdc), Cancer (rcdc), 4.2 Evaluation of markers and technologies (hrcs-rac), Cancer (hrcs-hc), 3 Good Health and Well Being (sdg), Humans (mesh), Male (mesh), Positron Emission Tomography Computed Tomography (mesh), Prostatic Neoplasms (mesh), Aged (mesh), Middle Aged (mesh), Retrospective Studies (mesh), Neoplasm Recurrence, Local (mesh), Cross-Sectional Studies (mesh), Prostate-Specific Antigen (mesh), Antigens, Surface (mesh), Nitriles (mesh), Phenylthiohydantoin (mesh), Neoplasm Staging (mesh), Leuprolide (mesh), Glutamate Carboxypeptidase II (mesh), Benzamides (mesh), Humans (mesh), Prostatic Neoplasms (mesh), Neoplasm Recurrence, Local (mesh), Benzamides (mesh), Nitriles (mesh), Phenylthiohydantoin (mesh), Leuprolide (mesh), Prostate-Specific Antigen (mesh), Glutamate Carboxypeptidase II (mesh), Antigens, Surface (mesh), Neoplasm Staging (mesh), Retrospective Studies (mesh), Cross-Sectional Studies (mesh), Aged (mesh), Middle Aged (mesh), Male (mesh), Positron Emission Tomography Computed Tomography (mesh), Humans (mesh), Male (mesh), Positron Emission Tomography Computed Tomography (mesh), Prostatic Neoplasms (mesh), Aged (mesh), Middle Aged (mesh), Retrospective Studies (mesh), Neoplasm Recurrence, Local (mesh), Cross-Sectional Studies (mesh), Prostate-Specific Antigen (mesh), Antigens, Surface (mesh), Nitriles (mesh), Phenylthiohydantoin (mesh), Neoplasm Staging (mesh), Leuprolide (mesh), Glutamate Carboxypeptidase II (mesh), Benzamides (mesh), 32 Biomedical and clinical sciences (for-2020), 42 Health sciences (for-2020)

Dateibeschreibung: application/pdf

Zugangs-URL: https://escholarship.org/uc/item/93x873j3
https://escholarship.org/content/qt93x873j3/qt93x873j3.pdf

The Oncometabolite 2-Hydroxyglutarate Is Upregulated in Post-Prostatectomy PSA Recurrence of Prostate Cancer: A Metabolomic Analysis

Autoren: Hairston, Dontrel W Spencer Sridharan-Weaver, Shamira Gandhi, Abheek et al.

Quelle: Molecules. 30(16)

Schlagwörter: 3404 Medicinal and Biomolecular Chemistry (for-2020), 3405 Organic Chemistry (for-2020), 34 Chemical Sciences (for-2020), Urologic Diseases (rcdc), Prevention (rcdc), Aging (rcdc), Cancer (rcdc), Prostate Cancer (rcdc), 2.1 Biological and endogenous factors (hrcs-rac), Cancer (hrcs-hc), Humans (mesh), Prostatic Neoplasms (mesh), Male (mesh), Prostatectomy (mesh), Prostate-Specific Antigen (mesh), Glutarates (mesh), Middle Aged (mesh), Metabolomics (mesh), Neoplasm Recurrence, Local (mesh), Aged (mesh), Up-Regulation (mesh), Metabolome (mesh), Biomarkers, Tumor (mesh), PSA, localized prostate cancer, phospholipids, triglycerides, tricarboxylic acid cycle, 2-hydroxyglutarate, Humans (mesh), Prostatic Neoplasms (mesh), Neoplasm Recurrence, Local (mesh), Glutarates (mesh), Prostate-Specific Antigen (mesh), Prostatectomy (mesh), Up-Regulation (mesh), Aged (mesh), Middle Aged (mesh), Male (mesh), Metabolomics (mesh), Metabolome (mesh), Biomarkers, Tumor (mesh), 2-hydroxyglutarate, PSA, localized prostate cancer, phospholipids, tricarboxylic acid cycle, triglycerides, Humans (mesh), Prostatic Neoplasms (mesh), Male (mesh), Prostatectomy (mesh), Prostate-Specific Antigen (mesh), Glutarates (mesh), Middle Aged (mesh), Metabolomics (mesh), Neoplasm Recurrence, Local (mesh), Aged (mesh), Up-Regulation (mesh), Metabolome (mesh), Biomarkers, Tumor (mesh), 0304 Medicinal and Biomolecular Chemistry (for), 0305 Organic Chemistry (for), 0307 Theoretical and Computational Chemistry (for), Organic Chemistry (science-metrix), 3404 Medicinal and biomolecular chemistry (for-2020), 3405 Organic chemistry (for-2020)

Zugangs-URL: https://escholarship.org/uc/item/8p20h143

Molecular Hallmarks of Prostate-specific Membrane Antigen in Treatment-naïve Prostate Cancer

Autoren: Weiner, Adam B Agrawal, Raag Wang, Nicholas K et al.

Quelle: European Urology. 86(6)

Schlagwörter: 32 Biomedical and Clinical Sciences (for-2020), 3202 Clinical Sciences (for-2020), 3211 Oncology and Carcinogenesis (for-2020), Cancer (rcdc), Aging (rcdc), Urologic Diseases (rcdc), Health Disparities (rcdc), Prostate Cancer (rcdc), Biomedical Imaging (rcdc), Genetics (rcdc), Radiation Oncology (rcdc), Minority Health (rcdc), Cancer (hrcs-hc), Male (mesh), Humans (mesh), Prostatic Neoplasms (mesh), Glutamate Carboxypeptidase II (mesh), Antigens, Surface (mesh), Aged (mesh), Positron-Emission Tomography (mesh), Biomarkers, Tumor (mesh), Middle Aged (mesh), Prostatic neoplasms/genetics, Prostatic neoplasms/pathology, Humans, Gene expression, Biomarkers, Tumor, Prognosis, Gene expression profiling, Humans (mesh), Prostatic Neoplasms (mesh), Glutamate Carboxypeptidase II (mesh), Antigens, Surface (mesh), Positron-Emission Tomography (mesh), Aged (mesh), Middle Aged (mesh), Male (mesh), Biomarkers, Tumor (mesh), Biomarkers, Gene expression, Gene expression profiling, Humans, Prognosis, Prostatic neoplasms/genetics, Prostatic neoplasms/pathology, Tumor, Male (mesh), Humans (mesh), Prostatic Neoplasms (mesh), Glutamate Carboxypeptidase II (mesh), Antigens, Surface (mesh), Aged (mesh), Positron-Emission Tomography (mesh), Biomarkers, Tumor (mesh), Middle Aged (mesh), 1103 Clinical Sciences (for), Urology & Nephrology (science-metrix), 3202 Clinical sciences (for-2020)

Dateibeschreibung: application/pdf

Zugangs-URL: https://escholarship.org/uc/item/9bt5w5vj
https://escholarship.org/content/qt9bt5w5vj/qt9bt5w5vj.pdf

Clinical Impact of Contouring Variability for Prostate Cancer Tumor Boost

Autoren: Zhong, Allison Y Lui, Asona J Kuznetsova, Svetlana et al.

Quelle: International Journal of Radiation Oncology • Biology • Physics. 120(4)

Schlagwörter: 5105 Medical and Biological Physics (for-2020), 32 Biomedical and Clinical Sciences (for-2020), 3202 Clinical Sciences (for-2020), 51 Physical Sciences (for-2020), 3211 Oncology and Carcinogenesis (for-2020), Cancer (rcdc), Prostate Cancer (rcdc), Aging (rcdc), Biomedical Imaging (rcdc), Urologic Diseases (rcdc), Radiation Oncology (rcdc), Clinical Research (rcdc), Cancer (hrcs-hc), Humans (mesh), Male (mesh), Prostatic Neoplasms (mesh), Radiotherapy Planning, Computer-Assisted (mesh), Magnetic Resonance Imaging (mesh), Radiation Oncologists (mesh), Tomography, X-Ray Computed (mesh), Observer Variation (mesh), Prospective Studies (mesh), Tumor Burden (mesh), Aged (mesh), Humans (mesh), Prostatic Neoplasms (mesh), Observer Variation (mesh), Tomography, X-Ray Computed (mesh), Magnetic Resonance Imaging (mesh), Radiotherapy Planning, Computer-Assisted (mesh), Tumor Burden (mesh), Prospective Studies (mesh), Aged (mesh), Male (mesh), Radiation Oncologists (mesh), Humans (mesh), Male (mesh), Prostatic Neoplasms (mesh), Radiotherapy Planning, Computer-Assisted (mesh), Magnetic Resonance Imaging (mesh), Radiation Oncologists (mesh), Tomography, X-Ray Computed (mesh), Observer Variation (mesh), Prospective Studies (mesh), Tumor Burden (mesh), Aged (mesh), 0299 Other Physical Sciences (for), 1103 Clinical Sciences (for), 1112 Oncology and Carcinogenesis (for), Oncology & Carcinogenesis (science-metrix), 3211 Oncology and carcinogenesis (for-2020), 3407 Theoretical and computational chemistry (for-2020), 5105 Medical and biological physics (for-2020)

Dateibeschreibung: application/pdf

Zugangs-URL: https://escholarship.org/uc/item/4j2051jc
https://escholarship.org/content/qt4j2051jc/qt4j2051jc.pdf

Upgrading of Grade Group 1 Prostate Cancer at Prostatectomy: Germline Risk Factors in a Prospective Cohort

Autoren: Liss, Michael A Zeltser, Nicole Zheng, Yingye et al.

Quelle: Cancer Epidemiology Biomarkers & Prevention. 33(11)

Schlagwörter: 32 Biomedical and Clinical Sciences (for-2020), 3202 Clinical Sciences (for-2020), 3211 Oncology and Carcinogenesis (for-2020), Prevention (rcdc), Urologic Diseases (rcdc), Human Genome (rcdc), Cancer Genomics (rcdc), Genetics (rcdc), Clinical Research (rcdc), Cancer (rcdc), Aging (rcdc), Prostate Cancer (rcdc), 4.2 Evaluation of markers and technologies (hrcs-rac), 4.1 Discovery and preclinical testing of markers and technologies (hrcs-rac), 2.1 Biological and endogenous factors (hrcs-rac), Cancer (hrcs-hc), 3 Good Health and Well Being (sdg), Humans (mesh), Male (mesh), Prostatic Neoplasms (mesh), Prostatectomy (mesh), Prospective Studies (mesh), Neoplasm Grading (mesh), Middle Aged (mesh), Risk Factors (mesh), Aged (mesh), Germ-Line Mutation (mesh), Humans (mesh), Prostatic Neoplasms (mesh), Prostatectomy (mesh), Risk Factors (mesh), Prospective Studies (mesh), Germ-Line Mutation (mesh), Aged (mesh), Middle Aged (mesh), Male (mesh), Neoplasm Grading (mesh), Humans (mesh), Male (mesh), Prostatic Neoplasms (mesh), Prostatectomy (mesh), Prospective Studies (mesh), Neoplasm Grading (mesh), Middle Aged (mesh), Risk Factors (mesh), Aged (mesh), Germ-Line Mutation (mesh), 11 Medical and Health Sciences (for), Epidemiology (science-metrix), 32 Biomedical and clinical sciences (for-2020), 42 Health sciences (for-2020)

Dateibeschreibung: application/pdf

Zugangs-URL: https://escholarship.org/uc/item/3hs7x827
https://escholarship.org/content/qt3hs7x827/qt3hs7x827.pdf

Quantitative MRI biomarker for classification of clinically significant prostate cancer: Calibration for reproducibility across echo times

Autoren: Kallis, Karoline Conlin, Christopher C Ollison, Courtney et al.

Quelle: Journal of Applied Clinical Medical Physics. 25(11)

Schlagwörter: 32 Biomedical and Clinical Sciences (for-2020), 3202 Clinical Sciences (for-2020), 3211 Oncology and Carcinogenesis (for-2020), Biomedical Imaging (rcdc), Prostate Cancer (rcdc), Urologic Diseases (rcdc), Aging (rcdc), Prevention (rcdc), Cancer (rcdc), Cancer (hrcs-hc), Humans (mesh), Male (mesh), Prostatic Neoplasms (mesh), Magnetic Resonance Imaging (mesh), Calibration (mesh), Aged (mesh), Middle Aged (mesh), Biomarkers, Tumor (mesh), Image Processing, Computer-Assisted (mesh), Reproducibility of Results (mesh), Prognosis (mesh), calibration, diffusion-weighted imaging, echo time, prostate cancer, quantitative biomarker, restricted spectrum imaging restriction score, Humans (mesh), Prostatic Neoplasms (mesh), Magnetic Resonance Imaging (mesh), Prognosis (mesh), Calibration (mesh), Reproducibility of Results (mesh), Image Processing, Computer-Assisted (mesh), Aged (mesh), Middle Aged (mesh), Male (mesh), Biomarkers, Tumor (mesh), calibration, diffusion‐weighted imaging, echo time, prostate cancer, quantitative biomarker, restricted spectrum imaging restriction score, Humans (mesh), Male (mesh), Prostatic Neoplasms (mesh), Magnetic Resonance Imaging (mesh), Calibration (mesh), Aged (mesh), Middle Aged (mesh), Biomarkers, Tumor (mesh), Image Processing, Computer-Assisted (mesh), Reproducibility of Results (mesh), Prognosis (mesh), 0299 Other Physical Sciences (for), 1103 Clinical Sciences (for), 1116 Medical Physiology (for), Nuclear Medicine & Medical Imaging (science-metrix), 3208 Medical physiology (for-2020), 5105 Medical and biological physics (for-2020)

Dateibeschreibung: application/pdf

Zugangs-URL: https://escholarship.org/uc/item/0q88v8zf
https://escholarship.org/content/qt0q88v8zf/qt0q88v8zf.pdf

PINK1-Mediated Mitochondrial Activity Confers Olaparib Resistance in Prostate Cancer Cells

Autoren: Schaaf, Zachary A Ning, Shu Leslie, Amy R et al.

Quelle: Cancer Research Communications. 4(11)

Schlagwörter: 32 Biomedical and Clinical Sciences (for-2020), 3211 Oncology and Carcinogenesis (for-2020), Prostate Cancer (rcdc), Cancer (rcdc), Urologic Diseases (rcdc), Aging (rcdc), 2.1 Biological and endogenous factors (hrcs-rac), Cancer (hrcs-hc), Humans (mesh), Male (mesh), Phthalazines (mesh), Piperazines (mesh), Prostatic Neoplasms (mesh), Drug Resistance, Neoplasm (mesh), Mitochondria (mesh), Cell Line, Tumor (mesh), Protein Kinases (mesh), Poly(ADP-ribose) Polymerase Inhibitors (mesh), Cell Line, Tumor (mesh), Mitochondria (mesh), Humans (mesh), Prostatic Neoplasms (mesh), Piperazines (mesh), Phthalazines (mesh), Protein Kinases (mesh), Drug Resistance, Neoplasm (mesh), Male (mesh), Poly(ADP-ribose) Polymerase Inhibitors (mesh), Humans (mesh), Male (mesh), Phthalazines (mesh), Piperazines (mesh), Prostatic Neoplasms (mesh), Drug Resistance, Neoplasm (mesh), Mitochondria (mesh), Cell Line, Tumor (mesh), Protein Kinases (mesh), Poly(ADP-ribose) Polymerase Inhibitors (mesh)

Dateibeschreibung: application/pdf

Zugangs-URL: https://escholarship.org/uc/item/05q1954m
https://escholarship.org/content/qt05q1954m/qt05q1954m.pdf

The Proteogenomics of Prostate Cancer Radioresistance

Autoren: Haas, Roni Frame, Gavin Khan, Shahbaz et al.

Quelle: Cancer Research Communications. 4(9)

Schlagwörter: 32 Biomedical and Clinical Sciences (for-2020), 3202 Clinical Sciences (for-2020), 3211 Oncology and Carcinogenesis (for-2020), Genetics (rcdc), Biotechnology (rcdc), Human Genome (rcdc), Radiation Oncology (rcdc), Cancer Genomics (rcdc), Prostate Cancer (rcdc), Urologic Diseases (rcdc), Aging (rcdc), Cancer (rcdc), Precision Medicine (rcdc), Cancer (hrcs-hc), Male (mesh), Humans (mesh), Prostatic Neoplasms (mesh), Radiation Tolerance (mesh), Proteogenomics (mesh), Cell Line, Tumor (mesh), DNA Polymerase theta (mesh), Genomic Instability (mesh), DNA Mismatch Repair (mesh), Gene Expression Regulation, Neoplastic (mesh), DNA-Directed DNA Polymerase (mesh), Radiation Dose Hypofractionation (mesh), Cell Line, Tumor (mesh), Humans (mesh), Prostatic Neoplasms (mesh), Genomic Instability (mesh), DNA-Directed DNA Polymerase (mesh), Gene Expression Regulation, Neoplastic (mesh), Radiation Tolerance (mesh), Male (mesh), DNA Mismatch Repair (mesh), Proteogenomics (mesh), Radiation Dose Hypofractionation (mesh), DNA Polymerase theta (mesh), Male (mesh), Humans (mesh), Prostatic Neoplasms (mesh), Radiation Tolerance (mesh), Proteogenomics (mesh), Cell Line, Tumor (mesh), DNA Polymerase theta (mesh), Genomic Instability (mesh), DNA Mismatch Repair (mesh), Gene Expression Regulation, Neoplastic (mesh), DNA-Directed DNA Polymerase (mesh), Radiation Dose Hypofractionation (mesh)

Dateibeschreibung: application/pdf

Zugangs-URL: https://escholarship.org/uc/item/7x67g8p6
https://escholarship.org/content/qt7x67g8p6/qt7x67g8p6.pdf

A phase I study of docetaxel plus synthetic lycopene in metastatic prostate cancer patients

Autoren: Lilly, Michael B Wu, Chunli Ke, Yu et al.

Quelle: Clinical and Translational Medicine. 14(3)

Schlagwörter: 4205 Nursing (for-2020), 42 Health Sciences (for-2020), Urologic Diseases (rcdc), Aging (rcdc), Cancer (rcdc), Prostate Cancer (rcdc), Clinical Research (rcdc), Clinical Trials and Supportive Activities (rcdc), 6.1 Pharmaceuticals (hrcs-rac), Cancer (hrcs-hc), Male (mesh), Humans (mesh), Docetaxel (mesh), Prostatic Neoplasms (mesh), Lycopene (mesh), Vascular Endothelial Growth Factor A (mesh), Androgen Antagonists (mesh), Androgens (mesh), Bayes Theorem (mesh), Endothelial Cells (mesh), docetaxel, lycopene, phase I trial, prostate cancer, docetaxel, lycopene, phase I trial, prostate cancer, Endothelial Cells (mesh), Humans (mesh), Prostatic Neoplasms (mesh), Androgen Antagonists (mesh), Vascular Endothelial Growth Factor A (mesh), Androgens (mesh), Bayes Theorem (mesh), Male (mesh), Docetaxel (mesh), Lycopene (mesh), docetaxel, lycopene, phase I trial, prostate cancer, Male (mesh), Humans (mesh), Docetaxel (mesh), Prostatic Neoplasms (mesh), Lycopene (mesh), Vascular Endothelial Growth Factor A (mesh), Androgen Antagonists (mesh), Androgens (mesh), Bayes Theorem (mesh), Endothelial Cells (mesh), 1110 Nursing (for), 4205 Nursing (for-2020)

Dateibeschreibung: application/pdf

Zugangs-URL: https://escholarship.org/uc/item/6b00t29h
https://escholarship.org/content/qt6b00t29h/qt6b00t29h.pdf

Targeting prostate tumor low–molecular weight tyrosine phosphatase for oxidation-sensitizing therapy

Autoren: Stanford, Stephanie M Nguyen, Tiffany P Chang, Joseph et al.

Quelle: Science Advances. 10(5)

Schlagwörter: 3101 Biochemistry and Cell Biology (for-2020), 32 Biomedical and Clinical Sciences (for-2020), 31 Biological Sciences (for-2020), 3202 Clinical Sciences (for-2020), 3211 Oncology and Carcinogenesis (for-2020), Genetics (rcdc), Urologic Diseases (rcdc), Aging (rcdc), Cancer (rcdc), Prostate Cancer (rcdc), 2.1 Biological and endogenous factors (hrcs-rac), Cancer (hrcs-hc), Male (mesh), Humans (mesh), Mice (mesh), Animals (mesh), Molecular Weight (mesh), Prostatic Neoplasms (mesh), Tyrosine (mesh), Protein Tyrosine Phosphatases (mesh), Animals (mesh), Humans (mesh), Mice (mesh), Prostatic Neoplasms (mesh), Tyrosine (mesh), Molecular Weight (mesh), Male (mesh), Protein Tyrosine Phosphatases (mesh), Male (mesh), Humans (mesh), Mice (mesh), Animals (mesh), Molecular Weight (mesh), Prostatic Neoplasms (mesh), Tyrosine (mesh), Protein Tyrosine Phosphatases (mesh)

Dateibeschreibung: application/pdf

Zugangs-URL: https://escholarship.org/uc/item/4xs9q63g
https://escholarship.org/content/qt4xs9q63g/qt4xs9q63g.pdf

Bone Biomarkers and Subsequent Survival in Men with Hormone-sensitive Prostate Cancer: Results from the SWOG S1216 Phase 3 Trial of Androgen Deprivation Therapy with or Without Orteronel

Autoren: Lara, Primo N Mayerson, Edward Gertz, Erik et al.

Quelle: European Urology. 85(2)

Schlagwörter: 32 Biomedical and Clinical Sciences (for-2020), 3202 Clinical Sciences (for-2020), 3211 Oncology and Carcinogenesis (for-2020), Clinical Trials and Supportive Activities (rcdc), Prostate Cancer (rcdc), Precision Medicine (rcdc), Urologic Diseases (rcdc), Aging (rcdc), Clinical Research (rcdc), Cancer (rcdc), Prevention (rcdc), 4.2 Evaluation of markers and technologies (hrcs-rac), 6.1 Pharmaceuticals (hrcs-rac), Cancer (hrcs-hc), Male (mesh), Humans (mesh), Prostatic Neoplasms (mesh), Androgen Antagonists (mesh), Androgens (mesh), Biomarkers (mesh), Prostatic Neoplasms, Castration-Resistant (mesh), Biomarkers, Tumor (mesh), Imidazoles (mesh), Naphthalenes (mesh), Prostate cancer, Bone turnover, Biomarkers, Overall survival, Prognostic, Predictive, Hormone sensitive, Humans (mesh), Prostatic Neoplasms (mesh), Imidazoles (mesh), Naphthalenes (mesh), Androgen Antagonists (mesh), Androgens (mesh), Male (mesh), Prostatic Neoplasms, Castration-Resistant (mesh), Biomarkers (mesh), Biomarkers, Tumor (mesh), Biomarkers, Bone turnover, Hormone sensitive, Overall survival, Predictive, Prognostic, Prostate cancer, Male (mesh), Humans (mesh), Prostatic Neoplasms (mesh), Androgen Antagonists (mesh), Androgens (mesh), Biomarkers (mesh), Prostatic Neoplasms, Castration-Resistant (mesh), Biomarkers, Tumor (mesh), Imidazoles (mesh), Naphthalenes (mesh), 1103 Clinical Sciences (for), Urology & Nephrology (science-metrix), 3202 Clinical sciences (for-2020)

Dateibeschreibung: application/pdf

Zugangs-URL: https://escholarship.org/uc/item/7zk7c2kx
https://escholarship.org/content/qt7zk7c2kx/qt7zk7c2kx.pdf

Impact of PSMA PET on Prostate Cancer Management

Autoren: Weiner, Adam B Agrawal, Raag Valle, Luca F et al.

Quelle: Current Treatment Options in Oncology. 25(2)

Schlagwörter: 32 Biomedical and Clinical Sciences (for-2020), 3202 Clinical Sciences (for-2020), 3211 Oncology and Carcinogenesis (for-2020), Urologic Diseases (rcdc), Minority Health (rcdc), Aging (rcdc), Biomedical Imaging (rcdc), Bioengineering (rcdc), Clinical Research (rcdc), Prostate Cancer (rcdc), Cancer (rcdc), Health Disparities (rcdc), 4.2 Evaluation of markers and technologies (hrcs-rac), Cancer (hrcs-hc), Humans (mesh), Male (mesh), Antigens, Surface (mesh), Neoplasm Staging (mesh), Positron Emission Tomography Computed Tomography (mesh), Prospective Studies (mesh), Prostatic Neoplasms (mesh), Radiopharmaceuticals (mesh), Prostate-Specific Antigen (mesh), Clinical decision-making, Drug therapy, Neoplasm staging, Positron-emission tomography, Prognosis, Prostatic neoplasms, Radiotherapy, Surgery, Theranostic nanomedicine, Humans (mesh), Prostatic Neoplasms (mesh), Prostate-Specific Antigen (mesh), Antigens, Surface (mesh), Radiopharmaceuticals (mesh), Neoplasm Staging (mesh), Prospective Studies (mesh), Male (mesh), Positron Emission Tomography Computed Tomography (mesh), Clinical decision-making, Drug therapy, Neoplasm staging, Positron-emission tomography, Prognosis, Prostatic neoplasms, Radiotherapy, Surgery, Theranostic nanomedicine, Humans (mesh), Male (mesh), Antigens, Surface (mesh), Neoplasm Staging (mesh), Positron Emission Tomography Computed Tomography (mesh), Prospective Studies (mesh), Prostatic Neoplasms (mesh), Radiopharmaceuticals (mesh), Prostate-Specific Antigen (mesh), Oncology & Carcinogenesis (science-metrix), 3211 Oncology and carcinogenesis (for-2020)

Dateibeschreibung: application/pdf

Zugangs-URL: https://escholarship.org/uc/item/3f5607n3
https://escholarship.org/content/qt3f5607n3/qt3f5607n3.pdf

Development of CD46 targeted alpha theranostics in prostate cancer using 134Ce/225Ac-Macropa-PEG4-YS5

Autoren: Bobba, Kondapa Naidu Bidkar, Anil P Wadhwa, Anju et al.

Quelle: Theranostics. 14(4)

Schlagwörter: 3206 Medical Biotechnology (for-2020), 32 Biomedical and Clinical Sciences (for-2020), 3211 Oncology and Carcinogenesis (for-2020), Cancer (rcdc), Radiation Oncology (rcdc), Biomedical Imaging (rcdc), Urologic Diseases (rcdc), Prostate Cancer (rcdc), Biotechnology (rcdc), Bioengineering (rcdc), Cancer (hrcs-hc), Male (mesh), Mice (mesh), Animals (mesh), Humans (mesh), Mice, Nude (mesh), Precision Medicine (mesh), Tissue Distribution (mesh), Radiopharmaceuticals (mesh), Prostatic Neoplasms (mesh), Chelating Agents (mesh), Membrane Cofactor Protein (mesh), targeted alpha therapy, PEG linkers, YS5 antibody, macropa, actinium-225, cerium-134, theranostics, Animals (mesh), Humans (mesh), Mice (mesh), Mice, Nude (mesh), Prostatic Neoplasms (mesh), Chelating Agents (mesh), Radiopharmaceuticals (mesh), Tissue Distribution (mesh), Male (mesh), Precision Medicine (mesh), Membrane Cofactor Protein (mesh), PEG linkers, YS5 antibody, actinium-225, cerium-134, macropa, targeted alpha therapy, theranostics, Male (mesh), Mice (mesh), Animals (mesh), Humans (mesh), Mice, Nude (mesh), Precision Medicine (mesh), Tissue Distribution (mesh), Radiopharmaceuticals (mesh), Prostatic Neoplasms (mesh), Chelating Agents (mesh), Membrane Cofactor Protein (mesh), 1112 Oncology and Carcinogenesis (for), 3211 Oncology and carcinogenesis (for-2020)

Dateibeschreibung: application/pdf

Zugangs-URL: https://escholarship.org/uc/item/3ng2x7z5
https://escholarship.org/content/qt3ng2x7z5/qt3ng2x7z5.pdf

Effect of glyceryl trinitrate and clevidipine administration on CT angiogram findings in dogs undergoing prostatic artery embolization for prostatic carcinoma

Autoren: Griffin, Maureen A Culp, William TN Chohan, Amandeep S et al.

Quelle: PLOS ONE. 19(12)

Schlagwörter: 3009 Veterinary Sciences (for-2020), 30 Agricultural, Veterinary and Food Sciences (for-2020), 32 Biomedical and Clinical Sciences (for-2020), Cardiovascular (rcdc), Biomedical Imaging (rcdc), Animals (mesh), Male (mesh), Dogs (mesh), Prostate (mesh), Prostatic Neoplasms (mesh), Vasodilator Agents (mesh), Nitroglycerin (mesh), Computed Tomography Angiography (mesh), Embolization, Therapeutic (mesh), Prospective Studies (mesh), Prostate (mesh), Animals (mesh), Dogs (mesh), Prostatic Neoplasms (mesh), Nitroglycerin (mesh), Vasodilator Agents (mesh), Embolization, Therapeutic (mesh), Prospective Studies (mesh), Male (mesh), Computed Tomography Angiography (mesh), Animals (mesh), Male (mesh), Dogs (mesh), Prostate (mesh), Prostatic Neoplasms (mesh), Vasodilator Agents (mesh), Nitroglycerin (mesh), Computed Tomography Angiography (mesh), Embolization, Therapeutic (mesh), Prospective Studies (mesh), General Science & Technology (science-metrix)

Dateibeschreibung: application/pdf

Zugangs-URL: https://escholarship.org/uc/item/7jq8j4n7
https://escholarship.org/content/qt7jq8j4n7/qt7jq8j4n7.pdf

Agent orange exposure and prostate cancer risk in the million veteran program

Autoren: Pagadala, Meghana S Lui, Asona J Zhong, Allison Y et al.

Quelle: Acta Oncologica. 63

Schlagwörter: 32 Biomedical and Clinical Sciences (for-2020), 3202 Clinical Sciences (for-2020), 3211 Oncology and Carcinogenesis (for-2020), Cancer (rcdc), Prostate Cancer (rcdc), Urologic Diseases (rcdc), Cancer (hrcs-hc), Humans (mesh), Male (mesh), Agent Orange (mesh), Prostatic Neoplasms (mesh), Veterans (mesh), Middle Aged (mesh), Aged (mesh), Vietnam Conflict (mesh), United States (mesh), Defoliants, Chemical (mesh), Risk Factors (mesh), 2, 4, 5-Trichlorophenoxyacetic Acid (mesh), 2, 4-Dichlorophenoxyacetic Acid (mesh), Polychlorinated Dibenzodioxins (mesh), Agent Orange, prostate cancer, MVP, race/ ethnicity, health disparities, Humans (mesh), Prostatic Neoplasms (mesh), 2, 4-Dichlorophenoxyacetic Acid (mesh), 2, 4, 5-Trichlorophenoxyacetic Acid (mesh), Defoliants, Chemical (mesh), Risk Factors (mesh), Vietnam Conflict (mesh), Aged (mesh), Middle Aged (mesh), Veterans (mesh), United States (mesh), Male (mesh), Polychlorinated Dibenzodioxins (mesh), Agent Orange (mesh), Humans (mesh), Male (mesh), Agent Orange (mesh), Prostatic Neoplasms (mesh), Veterans (mesh), Middle Aged (mesh), Aged (mesh), Vietnam Conflict (mesh), United States (mesh), Defoliants, Chemical (mesh), Risk Factors (mesh), 2, 4, 5-Trichlorophenoxyacetic Acid (mesh), 2, 4-Dichlorophenoxyacetic Acid (mesh), Polychlorinated Dibenzodioxins (mesh), 1112 Oncology and Carcinogenesis (for), Oncology & Carcinogenesis (science-metrix), 3211 Oncology and carcinogenesis (for-2020)

Dateibeschreibung: application/pdf

Zugangs-URL: https://escholarship.org/uc/item/2tx1t1b1
https://escholarship.org/content/qt2tx1t1b1/qt2tx1t1b1.pdf